Van 't Veer received the William L. McGuire Memorial Lecture Award at the San Antonio Breast Cancer Symposium for pioneering MammaPrint.
On December 11, 2024, at the renowned San Antonio Breast Cancer Symposium (SABCS) in the United States, Laura van 't Veer was honored with recognition including the prestigious William L. McGuire Memorial Lecture Award, one of the most respected honors in breast cancer research.
The SABCS is among the largest and most influential breast cancer research conferences in the world, attracting oncologists, researchers, and industry leaders from across the globe. The McGuire Memorial Lecture Award, named after a pioneering breast cancer researcher, is presented to individuals whose scientific contributions have profoundly shaped the understanding and treatment of breast cancer.
Van 't Veer's recognition at this symposium celebrated her pioneering work developing the MammaPrint genomic test, which by 2024 had been used to guide treatment decisions for hundreds of thousands of breast cancer patients internationally. Her lecture provided the global oncology community an opportunity to reflect on the evolution of genomic testing from her original 2001 discovery to its widespread clinical adoption.
This U.S. honor, coming alongside recognitions in Italy and the Netherlands within the same year, capped a remarkable year of international acknowledgment for van 't Veer, reflecting the truly global impact of her contributions to molecular breast cancer diagnostics over more than two decades.